SlipstreamJobs tracks this role from the company's public career site. Apply directly on the employer's site.
Ataraxis AI is a clinical AI research lab developing multi-modal AI methods to predict patient outcomes and treatment response in precision medicine. The company has raised over $24 million in funding (Series A led by Thiel Capital/Founders Fund, Obvious Ventures, and AIX Ventures) and counts Yann LeCun among its founding advisors. Ataraxis has launched clinical products including Ataraxis™ Breast, an AI-powered tool helping oncologists select optimal treatments for breast cancer patients across academic institutions and community clinics worldwide.
In this role, you will drive sales growth and market penetration of Ataraxis oncology products through direct sales to individual oncologists in your designated territory (Northwest TX/DFW region). You will be responsible for prospecting new business, maintaining relationships with existing customers, and closing deals in a hyper-growth startup environment. This is an autonomous, individual contributor role where you will operate independently and be empowered to shape the company's clinical AI deployment in oncology.
Ataraxis operates with a flat organizational structure where leadership roles are earned through demonstrated initiative and exceptional results. The company is seeking someone who can thrive in a competitive, fast-paced environment and effectively communicate AI-based diagnostic solutions to physicians.
REQUIREMENTS:
- Minimum 2 years of demonstrated high-performance sales experience in oncology, especially breast cancer
- Proven track record of consistently exceeding sales quotas with demonstrated achievement (e.g., President's Club, Rookie of the Year awards or recognition)
- Passionate about AI and innovation in healthcare; ability to learn and effectively communicate AI-based diagnostic solutions
- Autonomous and capable of excelling independently in a hyper-growth startup environment
- Ability to thrive in highly competitive environment; demonstrates resilience, urgency, and focus on closing deals
